Actym

Biotech developing truly disruptive Immuno-oncology platform

Raised

$34M

Follow us

Also headquartered in San Francisco

Companies in the same industry

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Latest funding

$34,000,000

Venture capital (Series A) - 2020

Illumina Ventures Korea Investment Partners (KIP) Boehringer Ingelheim Venture Fund (BIVF) +2

Team Size

1–10

Employees

Location

Headquarters

$34,000,000 Venture capital (Series A)